This is the first study of MSM supplementation on markers of joint health to be carried out in healthy adults; and it highlights the potential of OptiMSM® to be effective at just 2 grams per day. This trial provides us with the confirmation that all the benefits reported from clinical and pre-clinical studies on patients with osteoarthritis could be applied to healthy adults, changing the landscape of joint health formulations by allowing more flexibility in formulation and messaging on pack!
The study, “Methylsulfonylmethane Improves Knee Quality of Life in Participants with Mild Knee Pain” is a randomized, double-blind, placebo-controlled trial that set out to evaluate the effects of oral consumption of MSM in relieving mild knee joint pain. Published in the scientific journal Nutrients, the study evaluated 88 healthy adults who were experiencing mild pain in the knee joint(s), and consumed 2g of OptiMSM® or a placebo daily for 12 weeks.
Reach out to our Balchem experts for questions and help to formulate your next product with OptiMSM®.
Fill out the form below, and we will be in touch shortly.